Important players in carcinogenesis as potential targets in cancer therapy: an update

Justyna Magdalena Hermanowicz; Iwona Kwiatkowska; Dariusz Pawlak

doi:10.18632/oncotarget.27689

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Important players in carcinogenesis as potential targets in cancer therapy: an update

Justyna Magdalena Hermanowicz _, Iwona Kwiatkowska and Dariusz Pawlak

PDF | Full Text | How to cite

Oncotarget. 2020; 11:3078-3101. https://doi.org/10.18632/oncotarget.27689

Metrics: PDF 1698 views | Full Text 2483 views | ?

Abstract

Justyna Magdalena Hermanowicz1^,2, Iwona Kwiatkowska1 and Dariusz Pawlak1

1 Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza, Bialystok, Poland

2 Department of Clinical Pharmacy, Medical University of Bialystok, Mickiewicza, Bialystok, Poland

Correspondence to:

Justyna Magdalena Hermanowicz,

email:

[email protected]

Keywords: modulators of carcinogenesis; acetylcholine; peroxisome proliferator-activated receptors; aquaporins

Received: June 02, 2020 Accepted: July 14, 2020 Published: August 11, 2020

ABSTRACT

The development of cancer is a problem that has accompanied mankind for years. The growing number of cases, emerging drug resistance, and the need to reduce the serious side effects of pharmacotherapy are forcing scientists to better understand the complex mechanisms responsible for the initiation, promotion, and progression of the disease. This paper discusses the modulation of the particular stages of carcinogenesis by selected physiological factors, including: acetylcholine (ACh), peroxisome proliferator-activated receptors (PPAR), fatty acid-binding proteins (FABPs), Bruton’s tyrosine kinase (Btk), aquaporins (AQPs), insulin-like growth factor-2 (IGF-2), and exosomes. Understanding their role may contribute to the development of more effective and safer therapies based on new binding sites.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27689

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Important players in carcinogenesis as potential targets in cancer therapy: an update

Abstract